News

October 26, 2022

New strategy shows potential to block nerve loss in neurodegenerative diseases

Research into how key molecule triggers axon death may lead to new therapies.

News Release

October 20, 2020

Startup company founded by Washington University scientists acquired by Eli Lilly

Drugmaker purchases Disarm Therapeutics to develop treatments for neurodegenerative diseases.

Medical Campus & Community